Thermage, the anti-wrinkle company, suffers IPO bumbs — prices below forecast
Thermage, the Hayward maker of devices to treat wrinkles, priced six million common shares in its IPO at $7 per share, to raise $42 million.
It had originally wanted to raise $86 million, but lowered its pricing plans, first to between $11 and $13, but later to between $8 and $9.
Its Nasdaq ticker is THRM.
Thermage had raised $48 million from DFJ, Essex Woodlands Health Ventures, Institutional Venture Partners, Morgenthaler and Technology Partners.
Next Story: Kohlberg Kravis Roberts tried to take private equity public, not doing well
Previous Story: AOL acquires financial news search technology company, Relegence
